Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Dora Reglödi is active.

Publication


Featured researches published by Dora Reglödi.


Neuroscience | 2006

Effect of pituitary adenylate cyclase activating polypeptide-38 on sensory neuropeptide release and neurogenic inflammation in rats and mice

József Németh; Dora Reglödi; Gabor Pozsgai; Árpád Szabó; Krisztián Elekes; Erika Pintér; János Szolcsányi; Z. Helyes

Substance P (SP) and calcitonin gene-related peptide (CGRP), released from capsaicin-sensitive sensory nerves induce local neurogenic inflammation, while somatostatin exerts systemic anti-inflammatory actions. The aim of the present study was to investigate the release of pituitary adenylate cyclase activating polypeptide-38 (PACAP-38) and its effects on sensory neuropeptide release in vitro and acute neurogenic ear swelling in vivo. Capsaicin (10(-6) M) or electrical field stimulation (EFS; 40 V, 0.1 ms, 10 Hz, 120 s; 1200 impulses)-induced release of PACAP-38, SP, CGRP and somatostatin from isolated rat tracheae was measured with radioimmunoassay. Mustard oil-induced neurogenic inflammation in the mouse ear was determined with a micrometer and in the rat hind paw skin by the Evans Blue leakage technique. Capsaicin and EFS evoked 27% and more than twofold elevation of PACAP-38 release respectively, compared with the prestimulated basal values from isolated trachea preparation. Exogenously administered PACAP-38 (20-2000 nM) diminished both capsaicin- and EFS-evoked sensory neuropeptide release in a concentration-dependent manner. The maximal inhibitory effects of PACAP on capsaicin-induced substance P, CGRP and somatostatin release amounted to 75.4%, 73.3% and 90.0%, while EFS-evoked release of these peptides was 80.03%, 87.7% and 67.7%. In case of capsaicin stimulation the EC50 values for substance P, CGRP and somatostatin were 82.9 nM, 60.1 nM and 66.9 nM, respectively. When EFS was performed, these corresponding EC50 data were 92.1 nM, 67.8 nM and 20.9 nM. PACAP-38 (10, 100 and 1000 microg/kg i.p. in 200 microl volume) inhibited neurogenic ear swelling in the mouse. Furthermore, 100 microg/kg i.p. PACAP also significantly diminished mustard oil-evoked plasma protein extravasation in the rat skin. These results suggest that PACAP-38 is released from the stimulated peripheral terminals of capsaicin-sensitive afferents and it is able to inhibit the outflow of sensory neuropeptides. Based on this mechanism of action PACAP is also able to effectively diminish/abolish neurogenic inflammatory response in vivo after systemic administration.


Peptides | 2007

Inhibitory effect of PACAP-38 on acute neurogenic and non-neurogenic inflammatory processes in the rat.

Z. Helyes; Gabor Pozsgai; Rita Börzsei; József Németh; Teréz Bagoly; László Márk; Erika Pintér; Gábor K. Tóth; Krisztián Elekes; János Szolcsányi; Dora Reglödi

Inhibitory actions of pituitary adenylate cyclase activating polypeptide (PACAP) have been described on cellular/vascular inflammatory components, but there are few data concerning its role in neurogenic inflammation. In this study we measured PACAP-like immunoreactivity with radioimmunoassay in the rat plasma and showed a two-fold elevation in response to systemic stimulation of capsaicin-sensitive sensory nerves by resiniferatoxin, but not after local excitation of cutaneous afferents. Neurogenic plasma extravasation in the plantar skin induced by intraplantar capsaicin or resiniferatoxin, as well as carrageenan-induced paw edema were significantly diminished by intraperitoneal PACAP-38. In summary, these results demonstrate that PACAP is released from activated capsaicin-sensitive afferents into the systemic circulation. It diminishes acute pure neurogenic and mixed-type inflammatory reactions via inhibiting pro-inflammatory mediator release and/or by acting at post-junctional targets on the vascular endothelium.


Neuropeptides | 2006

Effect of PACAP in 6-OHDA-induced injury of the substantia nigra in intact young and ovariectomized female rats

Dora Reglödi; Andrea Lubics; Peter Kiss; I. Lengvári; Balázs Gaszner; Gábor K. Tóth; Orsolya Hegyi; Andrea Tamas

Pituitary adenylate cyclase activating polypeptide (PACAP) has neuroprotective effects in various neuronal cultures and in models of brain pathologies in vivo. Among others, it protects dopaminergic neurons in vitro, against 6-OHDA- and rotenone-induced injury. Recently, we have shown that PACAP reduces dopaminergic cell loss and ameliorates behavioral outcome following unilateral 6-OHDA-induced injury of the substantia nigra in male rats. However, after castration, PACAP led only to a slight amelioration of the behavioral symptoms. The aim of the present study was to investigate the degree of neuroprotection exerted by PACAP in female rats, using the same model. It was found that PACAP had no effect on the dopaminergic cell loss in intact female rats, only caused amelioration of certain acute behavioral signs. In contrast, PACAP effectively increased dopaminergic cell survival and decreased behavioral deficits in ovariectomized females. These results indicate that the neuroprotective effect of PACAP in a rat model of Parkinsons disease is gender-specific.


Neurotoxicity Research | 2005

Development of neurological reflexes and motor coordination in rats neonatally treated with monosodium glutamate

Peter Kiss; Andrea Tamas; Andrea Lubics; M. Szalai; L. Szalontay; I. Lengvári; Dora Reglödi

Monosodium glutamate (MSG) treatment of neonatal rats causes neuronal degeneration in various brain areas and leads to several neurochemical, endocrinological and behavioral alterations. However, relatively little is known about the development of neurological reflexes and motor coordination of these animals. Therefore, the aim of the present study was to examine the neurobehavioral development of newborn rats treated with MSG. Rats received MSG at postnatal days 1, 3, 5, 7, and 9. Appearance of neural reflexes and reflex performance as well as motor coordination were examined for 5 weeks after birth. The efficacy of MSG treatment was confirmed by histological examination of the arcuate nucleus. We found that MSG treatment delayed the appearance of forelimb placing, forelimb grasp and righting reflexes, besides the retarded somatic development. The treated pups performed surface righting in significantly longer times. Also, worse performance was observed in the foot-fault and rota-rod tests. However, MSG-treated rats reached control levels by the end of the fifth postnatal week. These results show that MSG treatment does not cause permanent alterations in the neurobehavioral development, only delays the appearance of some reflexes and leads to temporary changes in reflex performance and motor coordination signs.


Annals of the New York Academy of Sciences | 2006

Comparative Study of the Effects of PACAP in Young, Aging, and Castrated Males in a Rat Model of Parkinson's Disease

Dora Reglödi; Andrea Tamas; I. Lengvári; Gábor K. Tóth; L. Szalontay; Andrea Lubics

Abstract:u2002 We have previously shown that PACAP ameliorates the neurological symptoms and reduces the dopaminergic cell loss in young male rats, in a 6‐hydroxydopamine (6‐OHDA)‐induced lesion of the substantia nigra, a model of Parkinsons disease. In the present study, we compared the effects of PACAP in young, aging, and castrated males. Our results show that PACAP significantly reduced the dopaminergic cell loss in young and aging males. In castrated males, 6‐OHDA did not induce such a severe cell loss, and it was not altered by PACAP. However, PACAP effectively ameliorated behavioral symptoms in all groups, with a degree of recovery depending on age and endocrine status.


Annals of the New York Academy of Sciences | 2006

Effects of Systemic PACAP Treatment in Monosodium Glutamate‐Induced Behavioral Changes and Retinal Degeneration

Peter Kiss; Andrea Tamas; Andrea Lubics; I. Lengvári; M. Szalai; D. Hauser; Z.S. Horvath; Boglarka Racz; Robert Gábriel; Norbert Babai; Gábor K. Tóth; Dora Reglödi

Abstract:u2002 The present article investigated effects of systemic pituitary adenylate cyclase‐activating polypeptide (PACAP) treatment in monosodium glutamate (MSG)‐induced retinal degeneration and neurobehavioral alterations in neonatal rats. It was found that the dose of PACAP that effectively enhances neurobehavioral development in normal rats was able to counteract the retarding effect of MSG on righting, forelimb placing, and grasp reflexes and caused a significant amelioration of the righting and gait reflex performance and motor coordination at 2 weeks of age. In the retina, significant amelioration of neuronal loss in the inner retinal layers was achieved, but it was much less than that observed by local administration.


Annals of the New York Academy of Sciences | 2006

Protective effects of PACAP in excitotoxic striatal lesion

Andrea Tamas; Andrea Lubics; I. Lengvári; Dora Reglödi

Abstract:u2002 The present article investigated the effects of pituitary adenylate cyclase‐activating polypeptide (PACAP) treatment in a quinolinic acid (QA)‐induced unilateral lesion of the striatum, a model of Huntington`s disease (HD). PACAP was given locally, preceding the lesion. Behavioral analysis was performed after 1, 10, and 30 days, when motor activity and asymmetrical signs were evaluated. Three weeks after the treatment, a catalepsy test was performed by haloperidol administration, and finally histological assessment of the striatum was done. Our results show that PACAP treatment attenuated the behavioral deficits and reduced the number of lesioned neurons in the striatum.


Annals of the New York Academy of Sciences | 2006

Short-term fasting differentially alters PACAP and VIP levels in the brains of rat and chicken

Rita Jozsa; József Németh; Andrea Tamas; Tibor Hollosy; Andrea Lubics; Balázs Jakab; Andras Olah; I. Lengvári; Akira Arimura; Dora Reglödi

Abstract:u2002 The present article investigated the levels of pituitary adenylate cyclase‐activating polypeptide (PACAP) and vasoactive intestinal polypeptide (VIP) in the brains of rats and chickens 12, 36, and 84 h after starvation. PACAP levels increased in both species, 12 h after food deprivation in rats, and with a 24‐h delay in chickens. VIP levels showed a more complex pattern: a gradual increase in the hypothalamus and telencephalon, and a significant decrease in the brain stem of rats. In chickens, a decrease was observed in every brain area after 36 h of starvation. These data show that PACAP and VIP are differentially regulated and are involved in the regulatory processes under a food‐restricted regimen, and are differentially altered in nocturnal and diurnal species.


Annals of the New York Academy of Sciences | 2006

Comparative Anatomy of PACAP-Immunoreactive Structures in the Ventral Nerve Cord Ganglia of Lumbricid Oligochaetes

László Molnár; Edit Pollák; Ákos Boros; Dora Reglödi; Andrea Tamas; Isrvan Lengvari; Akira Arimura; Andrea Lubics

Abstract:u2002 By means of a whole mount immunocytochemical approach, the distribution patterns of pituitary adenylate cyclase‐activating polypeptide (PACAP)‐27 and PACAP‐38 were identified in the ventral nerve cord (VNC) ganglia of the earthworms Eisenia fetida and Lumbricus terrestris. Each PACAP form appears to occur in a distinct neuron population. Positions of these populations, as well as numbers and sizes of the constituting neurons do not essentially differ between the two species. The data suggest that in Lumbricid Oligochaetes, PACAP‐27 and PACAP‐38 neuron populations may mediate distinct physiological processes.


Annals of the New York Academy of Sciences | 2006

Changes in PACAP levels in the central nervous system after ovariectomy and castration

József Németh; Andrea Tamas; Rita Jozsa; Judit Horváth; Balázs Jakab; I. Lengvári; Akira Arimura; Andrea Lubics; Dora Reglödi

Abstract:u2002 The aim of the present article was to investigate the influence of gonadectomy on pituitary adenylate cyclase‐activating polypeptide (PACAP) levels in different brain areas. In males, there seems to be an inverse relationship between gonadotropins and PACAP in the brain in the acute phase of castration: PACAP levels decreased in almost all brain areas examined within the first week after castration. In females, such pattern was observed in the hypothalamus, brain stem, and temporal cortex. In the pituitary, levels decreased only on the first day after ovariectomy, and later, as in the thalamus, increases were observed. Although the pattern of change showed gender differences, our results provide further evidence that levels of gonadotropins and possibly gonadotropin‐releasing hormone influence PACAP levels and that PACAP is involved in the regulation of gonadal functions.

Collaboration


Dive into the Dora Reglödi's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

I. Lengvári

Hungarian Academy of Sciences

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Balázs Jakab

Hungarian Academy of Sciences

View shared research outputs
Top Co-Authors

Avatar

Rita Jozsa

Hungarian Academy of Sciences

View shared research outputs
Top Co-Authors

Avatar

Andras Olah

Hungarian Academy of Sciences

View shared research outputs
Researchain Logo
Decentralizing Knowledge